Manon Cox, Ph.D., MBA

Doctorate from the University of Wageningen. MBA with distinction from the University of Nyenrode and the University of Rochester, NY. Doctorandus degree in Molecular Biology, Genetics and Biochemistry from the University of Nijmegen, The Netherlands. Co-founder of NextWaveBio. Led the development of Flublok®, the only FDA approved recombinant influenza vaccine while serving as President and Chief Executive Officer of Protein Sciences Corporation.